Does TOLVAPTAN Cause End stage renal disease? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of End stage renal disease have been filed in association with TOLVAPTAN (Jynarque). This represents 0.5% of all adverse event reports for TOLVAPTAN.
46
Reports of End stage renal disease with TOLVAPTAN
0.5%
of all TOLVAPTAN reports
1
Deaths
4
Hospitalizations
How Dangerous Is End stage renal disease From TOLVAPTAN?
Of the 46 reports, 1 (2.2%) resulted in death, 4 (8.7%) required hospitalization.
Is End stage renal disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOLVAPTAN. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does TOLVAPTAN Cause?
Death (800)
Thirst (624)
Off label use (560)
Renal impairment (534)
Underdose (448)
Product use in unapproved indication (446)
Wrong technique in product usage process (426)
Polyuria (390)
Product dose omission issue (379)
Inappropriate schedule of product administration (376)
What Other Drugs Cause End stage renal disease?
OMEPRAZOLE (10,356)
ESOMEPRAZOLE (10,231)
LANSOPRAZOLE (9,734)
PANTOPRAZOLE (8,523)
DEXLANSOPRAZOLE (4,800)
RABEPRAZOLE (1,295)
EMTRICITABINE\TENOFOVIR DISOPROXIL (721)
TENOFOVIR DISOPROXIL (558)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (462)
TACROLIMUS (361)
Which TOLVAPTAN Alternatives Have Lower End stage renal disease Risk?
TOLVAPTAN vs TOPAMAX
TOLVAPTAN vs TOPIRAMATE
TOLVAPTAN vs TOPOTECAN
TOLVAPTAN vs TOPOTECAN\TOPOTECAN
TOLVAPTAN vs TOPROL